Tivity Health, Inc. (TVTY) — Financial statements
Income statement, balance sheet, and cash flow for Tivity Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 481↑9.9% | 438↓61.3% | 1,131↑86.6% | 606↑8.9% | 557 | |
| Cost of Revenue | 278↑11.1% | 250↓63.1% | 678↑56.7% | 433↑9.4% | 396 | |
| Gross Profit | 203↑8.4% | 187↓58.7% | 453↑161.0% | 174↑7.6% | 161 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 42↓2.3% | 43↓60.9% | 110↑213.4% | 35 | 0.00 | |
| Selling & Marketing Expenses | 7↓46.5% | 12↓92.3% | 158 | 0.00 | 0.00 | |
| SG&A Expenses | 49↓12.1% | 55↓79.4% | 268↑663.4% | 35↑2.2% | 34 | |
| Other Expenses | 11↑13.8% | 10↓80.4% | 51↑988.0% | 5↑39.0% | 3 | |
| Operating Expenses | 60↓8.1% | 65↓79.6% | 319↑701.5% | 40↑5.5% | 38 | |
| Total Costs & Expenses | 338↑7.2% | 315↓68.4% | 997↑111.0% | 472↑9.0% | 433 | |
| Operating Results | ||||||
| Operating Income | 166↑202.1% | -163↑34.9% | -250↓285.6% | 135↑9.5% | 123 | |
| Depreciation & Amortization | 11↓75.4% | 46↓9.6% | 51↑988.0% | 5↑39.0% | 3 | |
| EBITDA | 180↑9.8% | 164↑182.3% | -199↓243.0% | 139↑10.3% | 126 | |
| EBIT | 168↑42.9% | 118↑147.2% | -250↓286.9% | 134↑11.0% | 120 | |
| Interest & Other Income | ||||||
| Net Interest Income | -35↑20.0% | -43↑43.2% | -77↓776.7% | -9↑44.1% | -16 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 35↓20.0% | 43↓43.2% | 77↑776.7% | 9↓44.1% | 16 | |
| Non-Operating Income | -2↑99.1% | -281 | 0.00↓100.0% | 0.90↓63.7% | 2 | |
| Other Income / Expenses | -32↓113.6% | 237↑409.6% | -77↓694.7% | -10↑46.8% | -18 | |
| Income Before Tax | 134↑79.7% | 74↑122.8% | -326↓361.2% | 125↑19.2% | 105 | |
| Income Tax Expense | 26↑50.3% | 18↑144.3% | -40↓246.4% | 27↓37.9% | 44 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 107↑88.8% | 57↑119.8% | -287↓393.0% | 98↑59.9% | 61 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 107↑88.8% | 57↑119.8% | -287↓393.0% | 98↑59.9% | 61 | |
| Bottom-Line Net Income | 107↑88.8% | 57↑119.8% | -287↓393.0% | 98↑59.9% | 61 | |
| EPS (Basic) | 2.18↑87.9% | 1.16↑118.8% | -6.17↓371.8% | 2.27↑45.5% | 1.56 | |
| EPS (Diluted) | 2.18↑87.9% | 1.16↑118.8% | -6.17↓371.8% | 2.27↑57.6% | 1.44 | |
| Weighted Average Shares | 49↑0.0% | 49↑5.8% | 47↑8.0% | 43↑9.4% | 39 | |
| Weighted Average Diluted Shares | 49↑0.0% | 49↑5.8% | 47↑8.0% | 43↑1.2% | 43 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.